Avatrombopag Impurity 67 - Request Quote
Avatrombopag Impurity 67
| SZ CAT No: | SZ-A084097 |
| CAS No | NA |
| Mol.F. | C29H34BrClN6O3S2 |
| Mol.Wt. |
694.1 |
| Inv. Status |
In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Avatrombopag Impurity 67 is chemically 1-(5-((4-(5-bromothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)-3-chloropyridin-2-yl)piperidine-4-carboxylic acid. Avatrombopag Impurity 67 is supplied with detailed characterization data compliant with regulatory guideline. Avatrombopag Impurity 67 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Avatrombopag.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Avatrombopag Impurity 67
Purchase Avatrombopag Impurity 67
Avatrombopag Impurity 67 suppliers
Avatrombopag Impurity 67 manufacturers
Avatrombopag Impurity 67 price
Order Avatrombopag Impurity 67
Enquire Avatrombopag Impurity 67
Avatrombopag Impurity 67 cost
Avatrombopag Impurity 67 Supplier
Avatrombopag Impurity 67 Distributor
Avatrombopag Impurity 67 for Method Validation
Avatrombopag Reference Standard
Avatrombopag Impurity 67 for ANDA Filing
Avatrombopag Impurity 67 for Forced Degradation Studies
Avatrombopag Impurity 67 Identification Standards
Avatrombopag Impurity 67 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.